MORLACCO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 5.393
AS - Asia 2.913
EU - Europa 1.690
AF - Africa 754
SA - Sud America 753
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 31
Totale 11.610
Nazione #
US - Stati Uniti d'America 5.012
SG - Singapore 1.072
BR - Brasile 490
CN - Cina 467
HK - Hong Kong 385
IT - Italia 335
VN - Vietnam 184
PL - Polonia 152
DE - Germania 151
FI - Finlandia 105
RU - Federazione Russa 86
FR - Francia 73
NL - Olanda 72
GB - Regno Unito 65
KR - Corea 59
IN - India 58
AR - Argentina 47
SE - Svezia 47
BJ - Benin 44
ID - Indonesia 41
ZA - Sudafrica 41
CA - Canada 39
SA - Arabia Saudita 36
TR - Turchia 35
IE - Irlanda 34
MX - Messico 34
AT - Austria 33
EC - Ecuador 32
JO - Giordania 30
PS - Palestinian Territory 30
AO - Angola 29
BE - Belgio 29
PK - Pakistan 29
UY - Uruguay 29
IQ - Iraq 28
PE - Perù 28
AL - Albania 27
JP - Giappone 27
SK - Slovacchia (Repubblica Slovacca) 27
TN - Tunisia 27
BA - Bosnia-Erzegovina 26
CH - Svizzera 26
CO - Colombia 26
LV - Lettonia 26
UA - Ucraina 26
BO - Bolivia 25
GR - Grecia 25
NC - Nuova Caledonia 25
PY - Paraguay 25
UZ - Uzbekistan 25
CZ - Repubblica Ceca 24
EG - Egitto 24
LC - Santa Lucia 24
MA - Marocco 24
YT - Mayotte 24
ES - Italia 23
NP - Nepal 23
CL - Cile 22
DZ - Algeria 22
GN - Guinea 22
KE - Kenya 22
NE - Niger 22
CI - Costa d'Avorio 21
CU - Cuba 21
GT - Guatemala 21
KZ - Kazakistan 21
NO - Norvegia 21
VE - Venezuela 21
AZ - Azerbaigian 20
BS - Bahamas 20
CD - Congo 20
CV - Capo Verde 20
CW - ???statistics.table.value.countryCode.CW??? 20
GA - Gabon 20
HU - Ungheria 20
KG - Kirghizistan 20
MY - Malesia 20
PA - Panama 20
AF - Afghanistan, Repubblica islamica di 19
BB - Barbados 19
DK - Danimarca 19
IL - Israele 19
LB - Libano 19
SY - Repubblica araba siriana 19
TT - Trinidad e Tobago 19
BD - Bangladesh 18
GM - Gambi 18
IR - Iran 18
RO - Romania 18
RS - Serbia 18
SN - Senegal 18
ZW - Zimbabwe 18
BF - Burkina Faso 17
BW - Botswana 17
BZ - Belize 17
CY - Cipro 17
DO - Repubblica Dominicana 17
JM - Giamaica 17
LY - Libia 17
MD - Moldavia 17
Totale 10.821
Città #
Fairfield 851
Ashburn 709
Singapore 529
Woodbridge 377
Hong Kong 369
Houston 333
Cambridge 297
Seattle 293
Wilmington 211
Chandler 184
Santa Clara 150
Beijing 132
Ann Arbor 128
Bytom 110
Boardman 100
San Diego 100
Padova 93
Ho Chi Minh City 67
Los Angeles 64
Munich 64
Medford 62
Princeton 62
São Paulo 61
Helsinki 56
Hefei 53
San Jose 49
New York 47
Seoul 45
Des Moines 44
Cotonou 42
Chicago 35
Dublin 29
Hanoi 29
Amman 28
Turku 27
Buffalo 26
Noumea 25
Castries 24
Orem 24
Riga 24
Warsaw 24
Luanda 23
Montevideo 23
Montreal 22
Conakry 21
Johannesburg 21
Milan 21
Ogden 21
Libreville 20
London 20
Nairobi 20
Tashkent 20
Brooklyn 19
Havana 19
Nassau 19
Panama City 19
Roxbury 19
Baku 18
Dakar 18
Stockholm 18
Bridgetown 17
Harare 17
Kinshasa 17
Tirana 17
Abidjan 16
Dallas 16
Dili 16
Nanjing 16
Niamey 16
Praia 16
Tokyo 16
Tunis 16
Willemstad 16
Antananarivo 15
Bamako 15
Bishkek 15
Brussels 15
Denver 15
Dushanbe 15
Guayaquil 15
Jinan 15
Managua 15
Nuremberg 15
Vienna 15
Belo Horizonte 14
Brasília 14
Dar es Salaam 14
Kingston 14
Kuala Lumpur 14
Lima 14
Ouagadougou 14
Amsterdam 13
Council Bluffs 13
Djibouti 13
Frankfurt am Main 13
Jeddah 13
Kampala 13
Kigali 13
Phoenix 13
Port Moresby 13
Totale 6.950
Nome #
The Role of Lymph Node Dissection in the Treatment of Bladder Cancer 232
Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance 219
Porcine Small Intestinal Submucosa (SIS) as a Suitable Scaffold for the Creation of a Tissue-Engineered Urinary Conduit: Decellularization, Biomechanical and Biocompatibility Characterization Using New Approaches 215
An unusual cystic presentation of ductal carcinoma of the prostate 214
Syphilis or cancer? A urological challenge 211
Does 1.5 T mpMRI play a definite role in detection of clinically significant prostate cancer? Findings from a prospective study comparing blind 24-core saturation and targeted biopsies with a novel data remodeling model 199
Adverse Disease Features in Gleason Score 3 + 4 “Favorable Intermediate-Risk” Prostate Cancer: Implications for Active Surveillance 194
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer 191
Development of a Surgical Safety Training Program and Checklist for Conversion during Robotic Partial Nephrectomies 190
The impact of COVID-19 pandemic on urological emergencies: a single-center experience 190
Urinary microbiome and urological cancers: a mini review 183
A retrospective multicentric analysis on testicular torsion: is there still something to learn? 183
Edges-On-Dartos: An Easy Way to Improve Graft Performance in Staged Hypospadias Repair 175
Urological Care and COVID-19: Looking Forward 168
Early salvage radiation therapy post-prostatectomy: Key considerations 167
Impact of metabolic syndrome on oncologic outcomes at radical prostatectomy 163
The impact of COVID-19 pandemic on pornography habits: a global analysis of Google Trends 161
Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy 158
Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence 156
Morbidity, mortality, and quality assessment following open radical cystectomy in elderly patients with bladder cancer 156
A Novel Hybrid Membrane for Urinary Conduit Substitutes Based on Small Intestinal Submucosa Coupled with Two Synthetic Polymers 151
Duplication of inferior vena cava with obstructed right ureter: An extremely rare anomaly 151
Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer 150
Frailty and elderly in urology: Is there an impact on post-operative complications? 147
Prostate cancer: more effective use of underutilized postoperative radiation therapy 146
High-risk prostate cancer: The role of surgical management 145
Genomic tests to guide prostate cancer management following diagnosis 145
Metabolic syndrome and stone disease 144
Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy 143
Treatment of M1a/M1b prostate cancer with or without radical prostatectomy at diagnosis 142
Metabolic syndrome and prostate cancer treatment 142
The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy 141
Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis 141
Preliminary In Vitro Assessment of Decellularized Porcine Descending Aorta for Clinical Purposes 140
The multifaceted long-term effects of the COVID-19 pandemic on urology 140
Hybrid Materials for Tissue Repair and Replacement: Another Frontier in Biomaterial Exploitation Focusing on Cardiovascular and Urological Fields 139
Comparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3 + 4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveillance 139
Minimally invasive urologic surgery is safe during COVID-19: experience from two high-volume centers in Italy 139
Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis 138
Arterial Fistula With Severe Hematuria After Ileal Conduit Diversion 138
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study 137
Mechanical characterization of porcine ureter for the evaluation of tissue-engineering applications 136
The New Prostate Cancer Grading System in High-risk Disease: A Big Step Forward? 136
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches 135
Transitional cell carcinoma recurrence impacting intestinal diversion after radical cystectomy. Oncologic outcomes of a rare site of recurrence 134
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil 132
Successful Treatment of Vesicovaginal Fistulas via an Abdominal Transvesical Approach: A Single-center 50-yr Experience 130
Is "extreme" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure? 129
Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse 128
Effect of Level of Urology Training on Gleason Score and Prostate Volume Estimation Agreement between Transrectal Ultrasound Guided Biopsy and Radical Prostatectomy Specimen 128
Bladder Substitution: The Role of Tissue Engineering and Biomaterials 126
Perioperative and Functional Results for Robot-assisted Radical Cystectomy with Totally Intracorporeal Neobladder in Male Patients via the Vesica Patavina (Ves.Pa.) Technique: IDEAL Stage 2a Report 126
Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series [Figure presented] 124
Cryopreservation effects on biological tissues: histological and mechanical assessments 123
Prostate biopsy after abdominoperineal resection: a diagnostic challenge 122
Spontaneous prostatic hematoma: an unusual presentation of prostatic cancer 119
Robot-assisted simple prostatectomy 118
Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer 118
Diagnosis of clinically significant prostate cancer after negative multiparametric magnetic resonance imaging 117
Risk-prediction tools in prostate cancer: The challenge of tailoring 117
Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy 116
Efficacy and safety of antegrade sclerotherapy for varicocele in pediatric patients: A systematic review 115
Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review 115
Role of targeted biopsy, perilesional biopsy, and random biopsy in prostate cancer diagnosis by mpMRI/transrectal ultrasonography fusion biopsy 115
Re: Maurice et al: Nonclinical factors predict selection of initial observation for renal cell Carcinoma (Urology 2015;86:892-900) 114
Metabolic syndrome and andrological diseases 113
Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg? 111
Surgical strategies for lymphocele prevention in minimally-invasive radical prostatectomy and lymph-node dissection: a systematic review 111
Open versus robotic-assisted partial nephrectomy: A multicenter comparison study of perioperative results and complications 110
Robotic partial nephrectomy for complex kidney cyst in a 4-year old boy: Points of technique 109
Tissue Engineering and Regenerative Medicine in Pediatric Urology: Urethral and Urinary Bladder Reconstruction 109
Impact of metabolic syndrome on functional outcomes and complications of surgical treatment of prostate cancer 109
Nadir creatinine as a predictor of renal outcomes in PUVs: A systematic review and meta-analysis 108
MP53-14 MULTIMODAL TREATMENT FOR HIGH-RISK PROSTATE CANCER WITH HIGH-DOSE INTENSITY-MODULATED RADIATION THERAPY, CONCURRENT INTENSIFIED-DOSE DOCETAXEL AND LONG-TERM ANDROGEN DEPRIVATION THERAPY AFTER RADICAL PROSTATECTOMY AND LYMPHADENECTOMY: RESULTS OF A PROSPECTIVE PHASE II TRIAL 103
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study 101
Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients 101
Predictors of Unfavorable Pathology in Patients with Incidental (pT1a-T1b) Prostate Cancer 99
Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer 99
Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program 89
Nomograms in Urologic Oncology: Lights and Shadows 89
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study 82
Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU - YAU Prostate Cancer Working Group multi-institutional study 78
Robotic ureteral reimplantation: systematic review and pooled analysis of comparative outcomes in adults 75
Transitional care in urology: the road to independence 72
Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis 68
Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies? 64
RISK OF ADVERSE RADICAL PROSTATECTOMY OUTCOMES IN PATIENTS DIAGNOSED WITH IUSP <= 2 PROSTATE CANCER ON MRI/TRUS FUSION BIOPSY 44
Totale 11.740
Categoria #
all - tutte 37.295
article - articoli 36.433
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 376
Totale 74.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021610 0 0 0 0 0 0 77 111 110 169 97 46
2021/2022966 76 142 73 79 46 87 82 68 31 57 66 159
2022/2023542 124 15 2 35 91 66 15 53 74 5 53 9
2023/2024463 20 52 48 38 31 47 32 21 35 36 44 59
2024/20252.128 7 121 81 78 246 54 87 201 187 126 394 546
2025/20265.226 369 760 1.217 1.509 838 433 100 0 0 0 0 0
Totale 11.740